- IBDEI0BE ; ; 01-AUG-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4)
- ;;=^IBE(358.4,
- ;;^UTILITY(U,$J,358.4,0)
- ;;=IMP/EXP SELECTION GROUP^358.4I^1182^1174
- ;;^UTILITY(U,$J,358.4,1,0)
- ;;=PHYSICIAN TELEPHONE CODES^1^1
- ;;^UTILITY(U,$J,358.4,2,0)
- ;;=NON-PHYSICIAN TELEPHONE CALLS^2^1
- ;;^UTILITY(U,$J,358.4,3,0)
- ;;=SEIZURES/EPILEPSY/SPELLS^1^2
- ;;^UTILITY(U,$J,358.4,4,0)
- ;;=CEREBROVASCULAR DISEASE^2^2
- ;;^UTILITY(U,$J,358.4,5,0)
- ;;=DIZZINESS^3^2
- ;;^UTILITY(U,$J,358.4,6,0)
- ;;=ENCEPHALOPATHY^4^2
- ;;^UTILITY(U,$J,358.4,7,0)
- ;;=HEADACHE^5^2
- ;;^UTILITY(U,$J,358.4,8,0)
- ;;=MOVEMENT DISORDERS^6^2
- ;;^UTILITY(U,$J,358.4,9,0)
- ;;=NEOPLASMS^7^2
- ;;^UTILITY(U,$J,358.4,10,0)
- ;;=NEURODEGENERATIVE DISEASE^8^2
- ;;^UTILITY(U,$J,358.4,11,0)
- ;;=SLEEP DISORDERS^9^2
- ;;^UTILITY(U,$J,358.4,12,0)
- ;;=SPECIAL SCREENING^10^2
- ;;^UTILITY(U,$J,358.4,13,0)
- ;;=OTHER^11^2
- ;;^UTILITY(U,$J,358.4,14,0)
- ;;=BODY MASS INDEX (BMI)^2^3
- ;;^UTILITY(U,$J,358.4,15,0)
- ;;=COUNSELING^3^3
- ;;^UTILITY(U,$J,358.4,16,0)
- ;;=PREVENTIVE HEALTH ENCOUNTER^1^3
- ;;^UTILITY(U,$J,358.4,17,0)
- ;;=HISTORY OF ILLNESS^4^3
- ;;^UTILITY(U,$J,358.4,18,0)
- ;;=LONG TERM DRUG USE^5^3
- ;;^UTILITY(U,$J,358.4,19,0)
- ;;=OTHER^11^3
- ;;^UTILITY(U,$J,358.4,20,0)
- ;;=SCREENING^6^3
- ;;^UTILITY(U,$J,358.4,21,0)
- ;;=TRANSPLANT^8^3
- ;;^UTILITY(U,$J,358.4,22,0)
- ;;=VACCINATIONS^9^3
- ;;^UTILITY(U,$J,358.4,23,0)
- ;;=WOMEN'S HEALTH^10^3
- ;;^UTILITY(U,$J,358.4,24,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^7^3
- ;;^UTILITY(U,$J,358.4,25,0)
- ;;=IMMUNIZATIONS^4^4
- ;;^UTILITY(U,$J,358.4,26,0)
- ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^4
- ;;^UTILITY(U,$J,358.4,27,0)
- ;;=COUNSELING RISK FACTOR REDUCTION^2^4
- ;;^UTILITY(U,$J,358.4,28,0)
- ;;=OTH PREVENTIVE MEDICINE SERVICES^5^4
- ;;^UTILITY(U,$J,358.4,29,0)
- ;;=PREVENTIVE MEDICINE,GROUP^8^4
- ;;^UTILITY(U,$J,358.4,30,0)
- ;;=PREVENTIVE HEALTH VISIT-EST PT^6^4
- ;;^UTILITY(U,$J,358.4,31,0)
- ;;=PREVENTIVE HEALTH VISIT-NEW PT^7^4
- ;;^UTILITY(U,$J,358.4,32,0)
- ;;=IMMUNIZATION ADMINISTRATION^3^4
- ;;^UTILITY(U,$J,358.4,33,0)
- ;;=RESPIRATORY^6^5
- ;;^UTILITY(U,$J,358.4,34,0)
- ;;=SLEEP TESTING AND EVAL^7^5
- ;;^UTILITY(U,$J,358.4,35,0)
- ;;=OXIMETRY^4^5
- ;;^UTILITY(U,$J,358.4,36,0)
- ;;=CPAP^1^5
- ;;^UTILITY(U,$J,358.4,37,0)
- ;;=EDUCATION/TRAINING^2^5
- ;;^UTILITY(U,$J,358.4,38,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^5^5
- ;;^UTILITY(U,$J,358.4,39,0)
- ;;=HOME SLEEP STUDIES^3^5
- ;;^UTILITY(U,$J,358.4,40,0)
- ;;=TELEHEALTH PATIENT SITE^8^5
- ;;^UTILITY(U,$J,358.4,41,0)
- ;;=WIRELESS MONITOR OF PAP DEVICES^9^5
- ;;^UTILITY(U,$J,358.4,42,0)
- ;;=NEW PATIENT^2^6
- ;;^UTILITY(U,$J,358.4,43,0)
- ;;=ESTABLISHED PATIENT^1^6
- ;;^UTILITY(U,$J,358.4,44,0)
- ;;=CONSULTATIONS^3^6
- ;;^UTILITY(U,$J,358.4,45,0)
- ;;=PULMONARY DIAGNOSES^2^7
- ;;^UTILITY(U,$J,358.4,46,0)
- ;;=SLEEP DX PRELIMINARY^3^7
- ;;^UTILITY(U,$J,358.4,47,0)
- ;;=SLEEP DX CONFIRMED^4^7
- ;;^UTILITY(U,$J,358.4,48,0)
- ;;=OTHER SLEEP RELATED DX^6^7
- ;;^UTILITY(U,$J,358.4,49,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^5^7
- ;;^UTILITY(U,$J,358.4,50,0)
- ;;=OBESITY & BMI DX^1^7
- ;;^UTILITY(U,$J,358.4,51,0)
- ;;=SPECIAL SERVICES^10^8
- ;;^UTILITY(U,$J,358.4,52,0)
- ;;=CHEMO NURSE PROCEDURES^2^8
- ;;^UTILITY(U,$J,358.4,53,0)
- ;;=INFUSION DRUGS^7^8
- ;;^UTILITY(U,$J,358.4,54,0)
- ;;=BLOOD PRODUCTS^1^8
- ;;^UTILITY(U,$J,358.4,55,0)
- ;;=DIAGNOSTIC PROCEDURES^3^8
- ;;^UTILITY(U,$J,358.4,56,0)
- ;;=OTHER DRUGS^8^8
- ;;^UTILITY(U,$J,358.4,57,0)
- ;;=IMMUNIZATION ADMINISTRATION^5^8
- ;;^UTILITY(U,$J,358.4,58,0)
- ;;=IMMUNIZATIONS^6^8
- ;;^UTILITY(U,$J,358.4,59,0)
- ;;=PROLONGED SVC-MD/NP/PA^9^8
- ;;^UTILITY(U,$J,358.4,60,0)
- ;;=EDUCATION/TRAINING^4^8
- ;;^UTILITY(U,$J,358.4,61,0)
- ;;=NEW PATIENT^2^9
- ;;^UTILITY(U,$J,358.4,62,0)
- ;;=ESTABLISHED PATIENT^1^9
- ;;^UTILITY(U,$J,358.4,63,0)
- ;;=CONSULTATIONS^3^9
- ;;^UTILITY(U,$J,358.4,64,0)
- ;;=COMPLEX CHRONIC CARE^4^9
- ;;^UTILITY(U,$J,358.4,65,0)
- ;;=ANEMIA^1^10
- ;;^UTILITY(U,$J,358.4,66,0)
- ;;=ARTIFICIAL OPENING STATUS^2^10
- ;;^UTILITY(U,$J,358.4,67,0)
- ;;=BREASTS and GYN NEOPLASMS^3^10
- ;;^UTILITY(U,$J,358.4,68,0)
- ;;=COAGULATION DISORDERS^4^10
- ;;^UTILITY(U,$J,358.4,69,0)
- ;;=COUNSELING AND SCREENING^5^10
- ;;^UTILITY(U,$J,358.4,70,0)
- ;;=GENITOURINARY NEOPLASMS^6^10
- ;;^UTILITY(U,$J,358.4,71,0)
- ;;=GI CANCER^7^10
- ;;^UTILITY(U,$J,358.4,72,0)
- ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
- ;;^UTILITY(U,$J,358.4,73,0)
- ;;=HEMOGLOBINOPATHIES^9^10
- ;;^UTILITY(U,$J,358.4,74,0)
- ;;=LYMPHOID NEOPLASMS^10^10
- ;;^UTILITY(U,$J,358.4,75,0)
- ;;=METASTATIC SITES^13^10
- ;;^UTILITY(U,$J,358.4,76,0)
- ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
- ;;^UTILITY(U,$J,358.4,77,0)
- ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
- ;;^UTILITY(U,$J,358.4,78,0)
- ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
- ;;^UTILITY(U,$J,358.4,79,0)
- ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
- ;;^UTILITY(U,$J,358.4,80,0)
- ;;=PERSONAL HISTORY^19^10
- ;;^UTILITY(U,$J,358.4,81,0)
- ;;=MALNUTRITION^12^10
- ;;^UTILITY(U,$J,358.4,82,0)
- ;;=OTHER^18^10
- ;;^UTILITY(U,$J,358.4,83,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
- ;;^UTILITY(U,$J,358.4,84,0)
- ;;=ESTABLISHED PATIENT^1^11
- ;;^UTILITY(U,$J,358.4,85,0)
- ;;=CONSULTATIONS/OPINIONS^2^11
- ;;^UTILITY(U,$J,358.4,86,0)
- ;;=NEW PATIENTS^3^11
- ;;^UTILITY(U,$J,358.4,87,0)
- ;;=NEUROLOGY/SEIZURE^7^12
- ;;^UTILITY(U,$J,358.4,88,0)
- ;;=EEG^4^12
- ;;^UTILITY(U,$J,358.4,89,0)
- ;;=SLEEP TESTING^10^12
- ;;^UTILITY(U,$J,358.4,90,0)
- ;;=MUSCLE TESTING/EMG^6^12
- ;;^UTILITY(U,$J,358.4,91,0)
- ;;=EVOKED POTENTIAL^5^12
- ;;^UTILITY(U,$J,358.4,92,0)
- ;;=BIOPSY^2^12
- ;;^UTILITY(U,$J,358.4,93,0)
- ;;=AUTONOMIC FUNCTION TESTS^1^12
- ;;^UTILITY(U,$J,358.4,94,0)
- ;;=STEREOTACTIC^11^12
- ;;^UTILITY(U,$J,358.4,95,0)
- ;;=EDUCATION^3^12
- ;;^UTILITY(U,$J,358.4,96,0)
- ;;=NEUROSTIMULATORS^8^12
- ;;^UTILITY(U,$J,358.4,97,0)
- ;;=PROLONGED SERVICES^9^12
- ;;^UTILITY(U,$J,358.4,98,0)
- ;;=SEIZURES/EPILEPSY/SPELLS^16^13
- ;;^UTILITY(U,$J,358.4,99,0)
- ;;=CEREBROVASCULAR DISEASE^3^13
- ;;^UTILITY(U,$J,358.4,100,0)
- ;;=DIZZINESS^4^13
- ;;^UTILITY(U,$J,358.4,101,0)
- ;;=ENCEPHALOPATHY^6^13
- ;;^UTILITY(U,$J,358.4,102,0)
- ;;=HEADACHE^7^13
- ;;^UTILITY(U,$J,358.4,103,0)
- ;;=MOVEMENT DISORDERS^9^13
- ;;^UTILITY(U,$J,358.4,104,0)
- ;;=NEOPLASMS^11^13
- ;;^UTILITY(U,$J,358.4,105,0)
- ;;=NEURODEGENERATIVE DISEASE^12^13
- ;;^UTILITY(U,$J,358.4,106,0)
- ;;=OTHER^14^13
- ;;^UTILITY(U,$J,358.4,107,0)
- ;;=CARDIAC DISORDERS^2^13
- ;;^UTILITY(U,$J,358.4,108,0)
- ;;=INFLAMMATORY & DEMYELINATING DISEASES^8^13
- ;;^UTILITY(U,$J,358.4,109,0)
- ;;=NEUROMUSCULAR DISORDERS^13^13
- ;;^UTILITY(U,$J,358.4,110,0)
- ;;=PAIN^15^13
- ;;^UTILITY(U,$J,358.4,111,0)
- ;;=SPINAL CONDITIONS^18^13
- ;;^UTILITY(U,$J,358.4,112,0)
- ;;=SYMPTOMS^20^13
- ;;^UTILITY(U,$J,358.4,113,0)
- ;;=VISION DISTURBANCES^21^13
- ;;^UTILITY(U,$J,358.4,114,0)
- ;;=EMG DX^5^13
- ;;^UTILITY(U,$J,358.4,115,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^19^13
- ;;^UTILITY(U,$J,358.4,116,0)
- ;;=MUSCLE ATROPHY^10^13
- ;;^UTILITY(U,$J,358.4,117,0)
- ;;=BOTOX^1^13
- ;;^UTILITY(U,$J,358.4,118,0)
- ;;=SEQUELAE OF CEREBROVASCULAR DISEASE^17^13
- ;;^UTILITY(U,$J,358.4,119,0)
- ;;=ESTABLISHED PATIENT^1^14
- ;;^UTILITY(U,$J,358.4,120,0)
- ;;=CARE PLAN OVERSIGHT^1^15
- ;;^UTILITY(U,$J,358.4,121,0)
- ;;=OTHER SERVICES^4^15
- ;;^UTILITY(U,$J,358.4,122,0)
- ;;=CASE MANAGEMENT^2^15
- ;;^UTILITY(U,$J,358.4,123,0)
- ;;=EDUCATION^3^15
- ;;^UTILITY(U,$J,358.4,124,0)
- ;;=CARDIOVASCULAR DISORDERS^1^16
- ;;^UTILITY(U,$J,358.4,125,0)
- ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^16
- ;;^UTILITY(U,$J,358.4,126,0)
- ;;=DIABETES^4^16
- ;;^UTILITY(U,$J,358.4,127,0)
- ;;=EYE & EAR DISORDERS^4^16
- ;;^UTILITY(U,$J,358.4,128,0)
- ;;=MENTAL HEALTH^5^16
- ;;^UTILITY(U,$J,358.4,129,0)
- ;;=NEOPLASMS^6^16
- ;;^UTILITY(U,$J,358.4,130,0)
- ;;=NEUROLOGICAL CONDITIONS^7^16
- ;;^UTILITY(U,$J,358.4,131,0)
- ;;=OTHER CONDITIONS^8^16
- ;;^UTILITY(U,$J,358.4,132,0)
- ;;=RESPIRATORY DISORDERS^9^16
- ;;^UTILITY(U,$J,358.4,133,0)
- ;;=DEMENTIA^3^16
- ;;^UTILITY(U,$J,358.4,134,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^10^16
- ;;^UTILITY(U,$J,358.4,135,0)
- ;;=ASSESSMENT/COUNSELING^1^17
- ;;^UTILITY(U,$J,358.4,136,0)
- ;;=ONE ON ONE TRAINING^6^17
- ;;^UTILITY(U,$J,358.4,137,0)
- ;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^17
- ;;^UTILITY(U,$J,358.4,138,0)
- ;;=TEAM CONFERENCE^8^17
- ;;^UTILITY(U,$J,358.4,139,0)
- ;;=HOME VISIT^5^17
- ;;^UTILITY(U,$J,358.4,140,0)
- ;;=IMPAIRMENT CODES^1^18
- ;;^UTILITY(U,$J,358.4,141,0)
- ;;=CONTRIBUTORY CONDITION^2^18
- ;;^UTILITY(U,$J,358.4,142,0)
- ;;=TBI-RELATED CONTRIB COND^5^18
- ;;^UTILITY(U,$J,358.4,143,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^4^18
- ;;^UTILITY(U,$J,358.4,144,0)
- ;;=FAMILY HX EYE CONDITIONS^3^18
- ;;^UTILITY(U,$J,358.4,145,0)
- ;;=NEW PATIENT^2^19
- ;;^UTILITY(U,$J,358.4,146,0)
- ;;=ESTABLISHED PATIENT^1^19
- ;;^UTILITY(U,$J,358.4,147,0)
- ;;=CONSULTATIONS^3^19
- ;;^UTILITY(U,$J,358.4,148,0)
- ;;=ARRHYTHMIA^3^20
- ;;^UTILITY(U,$J,358.4,149,0)
- ;;=CHEST PAIN^4^20
- ;;^UTILITY(U,$J,358.4,150,0)
- ;;=CHF/MYOPATHY/TRANSPLANT^5^20
- ;;^UTILITY(U,$J,358.4,151,0)
- ;;=CORONARY ATHEROSCLEROSIS^6^20
- ;;^UTILITY(U,$J,358.4,152,0)
- ;;=GENERAL SYMPTOMS^9^20
- ;;^UTILITY(U,$J,358.4,153,0)
- ;;=HISTORY^12^20
- ;;^UTILITY(U,$J,358.4,154,0)
- ;;=HYPERTENSION/HYPOTENSION^13^20
- ;;^UTILITY(U,$J,358.4,155,0)
- ;;=INFECTION/INFLM DISEASE^14^20
- ;;^UTILITY(U,$J,358.4,156,0)
- ;;=LIPID DISORDER^15^20
- ;;^UTILITY(U,$J,358.4,157,0)
- ;;=MYOCARDIAL INFARCTION^17^20
- ;;^UTILITY(U,$J,358.4,158,0)
- ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^20
- ;;^UTILITY(U,$J,358.4,159,0)
- ;;=HEART DISEASE^10^20
- ;;^UTILITY(U,$J,358.4,160,0)
- ;;=HEART VALVE DISEASE^11^20
- ;;^UTILITY(U,$J,358.4,161,0)
- ;;=PERIPHERAL VASC DISEASE^20^20
- ;;^UTILITY(U,$J,358.4,162,0)
- ;;=RHEUMATIC HEART DISEASE^23^20
- ;;^UTILITY(U,$J,358.4,163,0)
- ;;=DEVICE/IMPLANT/GRAFT^7^20
- ;;^UTILITY(U,$J,358.4,164,0)
- ;;=SYNCOPE^26^20
- ;;^UTILITY(U,$J,358.4,165,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^24^20
- ;;^UTILITY(U,$J,358.4,166,0)
- ;;=ECTOPY^8^20
- ;;^UTILITY(U,$J,358.4,167,0)
- ;;=MISCELLANEOUS^16^20
- ;;^UTILITY(U,$J,358.4,168,0)
- ;;=VENTRICULAR ARRHYTHMIAS^27^20
- ;;^UTILITY(U,$J,358.4,169,0)
- ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^20
- ;;^UTILITY(U,$J,358.4,170,0)
- ;;=OTHER CARDIAC CONDITIONS^22^20
- ;;^UTILITY(U,$J,358.4,171,0)
- ;;=PULMONARY DISEASE^21^20
- ;;^UTILITY(U,$J,358.4,172,0)
- ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^20
- ;;^UTILITY(U,$J,358.4,173,0)
- ;;=ACSC CHF^1^20
- ;;^UTILITY(U,$J,358.4,174,0)
- ;;=ACSC HYPERTENSION^2^20
- ;;^UTILITY(U,$J,358.4,175,0)
- ;;=PACEMAKER^15^21
- ;;^UTILITY(U,$J,358.4,176,0)
- ;;=CORONARY ANGIOPLASTY & STENTS^3^21
- ;;^UTILITY(U,$J,358.4,177,0)
- ;;=ELECTROPHYSIOLOGICAL PROCs^7^21
- ;;^UTILITY(U,$J,358.4,178,0)
- ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^21
- ;;^UTILITY(U,$J,358.4,179,0)
- ;;=VASCULAR INJECTION PROCs^21^21
- ;;^UTILITY(U,$J,358.4,180,0)
- ;;=OTHER PROCEDURES^14^21
- ;;^UTILITY(U,$J,358.4,181,0)
- ;;=HEART CATHETERIZATIONS^8^21
- ;;^UTILITY(U,$J,358.4,182,0)
- ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^21
- ;;^UTILITY(U,$J,358.4,183,0)
- ;;=OTHER HEART CODES^13^21
- ;;^UTILITY(U,$J,358.4,184,0)
- ;;=PROSTHETIC ANEURYSM REPAIR^19^21
- ;;^UTILITY(U,$J,358.4,185,0)
- ;;=DEVICE PROGRAMMING^4^21
- ;;^UTILITY(U,$J,358.4,186,0)
- ;;=ECHO^5^21
- ;;^UTILITY(U,$J,358.4,187,0)
- ;;=EKG^6^21
- ;;^UTILITY(U,$J,358.4,188,0)
- ;;=MEDICATION ADMINISTRATION^9^21
- ;;^UTILITY(U,$J,358.4,189,0)
- ;;=MEDICATIONS^10^21
- ;;^UTILITY(U,$J,358.4,190,0)
- ;;=OTHER CARDIAC^12^21
- ;;^UTILITY(U,$J,358.4,191,0)
- ;;=STRESS TESTS^20^21
- ;;^UTILITY(U,$J,358.4,192,0)
- ;;=PREVENTIVE COUNSELING^17^21
- ;;^UTILITY(U,$J,358.4,193,0)
- ;;=MODERATE SEDATION (MS)^11^21
- ;;^UTILITY(U,$J,358.4,194,0)
- ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^21
- ;;^UTILITY(U,$J,358.4,195,0)
- ;;=CARDIOVERSION^1^21
- ;;^UTILITY(U,$J,358.4,196,0)
- ;;=PROLONGED SERVICES^18^21
- ;;^UTILITY(U,$J,358.4,197,0)
- ;;=NEW PATIENT^2^22
- ;;^UTILITY(U,$J,358.4,198,0)
- ;;=ESTABLISHED PATIENT^1^22
- ;;^UTILITY(U,$J,358.4,199,0)
- ;;=CONSULTATIONS^3^22
- ;;^UTILITY(U,$J,358.4,200,0)
- ;;=MISCELLANEOUS TREATMENT^4^23
- ;;^UTILITY(U,$J,358.4,201,0)
- ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^23
- ;;^UTILITY(U,$J,358.4,202,0)
- ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^23
- ;;^UTILITY(U,$J,358.4,203,0)
- ;;=ACUPUNCTURE^1^23
- ;;^UTILITY(U,$J,358.4,204,0)
- ;;=EDUCATION FOR SELF MGT^3^23
- ;;^UTILITY(U,$J,358.4,205,0)
- ;;=EXTREMITIES/JOINTS/MUSCLES^6^24
- ;;^UTILITY(U,$J,358.4,206,0)
- ;;=HEAD AREA/NERVES^1^24
- ;;^UTILITY(U,$J,358.4,207,0)
- ;;=CERVICAL^2^24
- ;;^UTILITY(U,$J,358.4,208,0)
- ;;=THORACIC^3^24
- ;;^UTILITY(U,$J,358.4,209,0)
- ;;=LUMBAR^4^24
- ;;^UTILITY(U,$J,358.4,210,0)
- ;;=SACRUM^5^24
- ;;^UTILITY(U,$J,358.4,211,0)
- ;;=UNSPECIFIED^8^24
- ;;^UTILITY(U,$J,358.4,212,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^7^24
- ;;^UTILITY(U,$J,358.4,213,0)
- ;;=NEW PATIENT^1^25
- ;;^UTILITY(U,$J,358.4,214,0)
- ;;=ESTABLISHED PATIENT^2^25
- ;;^UTILITY(U,$J,358.4,215,0)
- ;;=EDUCATION & TRAINING FOR SELF MGMT^4^25
- ;;^UTILITY(U,$J,358.4,216,0)
- ;;=MEDICATION ADMIN^7^25
- ;;^UTILITY(U,$J,358.4,217,0)
- ;;=IMMUNIZATION ADMINISTRATION^5^25
- ;;^UTILITY(U,$J,358.4,218,0)
- ;;=IMMUNIZATIONS^6^25
- ;;^UTILITY(U,$J,358.4,219,0)
- ;;=CONTINUOUS GLUCOSE MONITORING^3^25
- ;;^UTILITY(U,$J,358.4,220,0)
- ;;=ANTICOAGULATION^2^26
- ;;^UTILITY(U,$J,358.4,221,0)
- ;;=PAIN^6^26
- ;;^UTILITY(U,$J,358.4,222,0)
- ;;=MENTAL HEALTH^5^26
- ;;^UTILITY(U,$J,358.4,223,0)
- ;;=ENDOCRINE^4^26
- ;;^UTILITY(U,$J,358.4,224,0)
- ;;=CARDIOVASCULAR^3^26
- ;;^UTILITY(U,$J,358.4,225,0)
- ;;=RESPIRATORY^7^26
- ;;^UTILITY(U,$J,358.4,226,0)
- ;;=OTHER^8^26
- ;;^UTILITY(U,$J,358.4,227,0)
- ;;=COMMON DIAGNOSIS^1^26
- ;;^UTILITY(U,$J,358.4,228,0)
- ;;=NEW PATIENT^3^27
- ;;^UTILITY(U,$J,358.4,229,0)
- ;;=ESTABLISHED PATIENT^1^27
- ;;^UTILITY(U,$J,358.4,230,0)
- ;;=CONSULTATIONS^2^27
- ;;^UTILITY(U,$J,358.4,231,0)
- ;;=PREVENTIVE MEDICINE-EST PT^4^27
- ;;^UTILITY(U,$J,358.4,232,0)
- ;;=PREVENTIVE MEDICINE-NEW PT^5^27
- ;;^UTILITY(U,$J,358.4,233,0)
- ;;=RISK FACTOR REDUCTION-GRP^6^27
- ;;^UTILITY(U,$J,358.4,234,0)
- ;;=RISK FACTOR REDUCTION-IND^7^27
- ;;^UTILITY(U,$J,358.4,235,0)
- ;;=OTHER^3^28
- ;;^UTILITY(U,$J,358.4,236,0)
- ;;=EDUCATION/TRAINING^1^28
- ;;^UTILITY(U,$J,358.4,237,0)
- ;;=MEDICAL NUTRITION THERAPY^2^28
- ;;^UTILITY(U,$J,358.4,238,0)
- ;;=WOUND TREATMENT^5^28
- ;;^UTILITY(U,$J,358.4,239,0)
- ;;=PROLONGED SERVICES^4^28
- ;;^UTILITY(U,$J,358.4,240,0)
- ;;=DIABETES^1^29
- ;;^UTILITY(U,$J,358.4,241,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^3^29
- ;;^UTILITY(U,$J,358.4,242,0)
- ;;=SOCIAL DETERMINANTS OF HEALTH^2^29
- ;;^UTILITY(U,$J,358.4,243,0)
- ;;=IMMUNIZATION^10^30
- ;;^UTILITY(U,$J,358.4,244,0)
- ;;=MEDICATION^13^30
- ;;^UTILITY(U,$J,358.4,245,0)
- ;;=ORTHO/JOINTS^6^30
- ;;^UTILITY(U,$J,358.4,246,0)
- ;;=RESPIRATORY SYSTEM^14^30
- ;;^UTILITY(U,$J,358.4,247,0)
- ;;=CRITICAL CARE/PULM/SEDATION^3^30
- ;;^UTILITY(U,$J,358.4,248,0)
- ;;=GI/GYN^7^30
- ;;^UTILITY(U,$J,358.4,249,0)
- ;;=NEURO/EYE/ENT^8^30
- ;;^UTILITY(U,$J,358.4,250,0)
- ;;=LACERATIONS^5^30
- ;;^UTILITY(U,$J,358.4,251,0)
- ;;=SKIN WOUNDS/BURNS^4^30
- ;;^UTILITY(U,$J,358.4,252,0)
- ;;=PSYCHIATRY^9^30
- ;;^UTILITY(U,$J,358.4,253,0)
- ;;=COMMON PROCEDURES^1^30
- ;;^UTILITY(U,$J,358.4,254,0)
- ;;=INFUSION/INJECTION ADMIN^11^30
- ;;^UTILITY(U,$J,358.4,255,0)
- ;;=ADDITIONAL VISIT CODES^2^30
- ;;^UTILITY(U,$J,358.4,256,0)
- ;;=COVID-19 RELATED^12^30
- ;;^UTILITY(U,$J,358.4,257,0)
- ;;=HEDIS CODE/MISC HCPCS^15^30
- ;;^UTILITY(U,$J,358.4,258,0)
- ;;=LABS PERFORMED IN ED^16^30
- ;;^UTILITY(U,$J,358.4,259,0)
- ;;=EMERGENCY DEPT VISIT^1^31
- ;;^UTILITY(U,$J,358.4,260,0)
- ;;=TRIAGE ONLY (NO MD SEEN)^4^31
- ;;^UTILITY(U,$J,358.4,261,0)
- ;;=ED OBS 1ST DAY-INIT^3^31
- ;;^UTILITY(U,$J,358.4,262,0)
- ;;=ED OBS (ADMIT&D/C SAME DAY)^2^31
- ;;^UTILITY(U,$J,358.4,263,0)
- ;;=ED COMMON DIAGNOSES^1^32
- ;;^UTILITY(U,$J,358.4,264,0)
- ;;=ADMINISTRATIVE TOPICS^2^32
- ;;^UTILITY(U,$J,358.4,265,0)
- ;;=CARDIOVASCULAR^3^32
- ;;^UTILITY(U,$J,358.4,266,0)
- ;;=EAR/NOSE/THROAT^6^32
- ;;^UTILITY(U,$J,358.4,267,0)
- ;;=ENDO/RENAL/ELECTROLYTES^5^32
- ;;^UTILITY(U,$J,358.4,268,0)
- ;;=EYE^7^32
- ;;^UTILITY(U,$J,358.4,269,0)
- ;;=GI/ABDOMEN^8^32
- ;;^UTILITY(U,$J,358.4,270,0)
- ;;=PSYCHIATRY^17^32
- ;;^UTILITY(U,$J,358.4,271,0)
- ;;=LACERATION(S)^16^32
- ;;^UTILITY(U,$J,358.4,272,0)
- ;;=PULMONARY^18^32
- ;;^UTILITY(U,$J,358.4,273,0)
- ;;=GU/RECTAL^9^32
- ;;^UTILITY(U,$J,358.4,274,0)
- ;;=HEME/ONC/VASCULAR^10^32
- ;;^UTILITY(U,$J,358.4,275,0)
- ;;=INFECTIOUS DISEASE^11^32
- ;;^UTILITY(U,$J,358.4,276,0)
- ;;=MUSCULOSKELETAL/MISC^14^32
- ;;^UTILITY(U,$J,358.4,277,0)
- ;;=NEUROLOGY^15^32
- ;;^UTILITY(U,$J,358.4,278,0)
- ;;=SKIN^19^32
- ;;^UTILITY(U,$J,358.4,279,0)
- ;;=MUSCULOSKELETAL-LE^12^32
- ;;^UTILITY(U,$J,358.4,280,0)
- ;;=MUSCULOSKELETAL-UE^13^32
- ;;^UTILITY(U,$J,358.4,281,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^21^32
- ;;^UTILITY(U,$J,358.4,282,0)
- ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^32
- ;;^UTILITY(U,$J,358.4,283,0)
- ;;=FALLS^22^32
- ;;^UTILITY(U,$J,358.4,284,0)
- ;;=VEHICLE ACCIDENTS^24^32
- ;;^UTILITY(U,$J,358.4,285,0)
- ;;=EXTERNAL CAUSES^26^32
- ;;^UTILITY(U,$J,358.4,286,0)
- ;;=PAIN^20^32
- ;;^UTILITY(U,$J,358.4,287,0)
- ;;=BITES-HUMAN/ANIMAL/INSECT^23^32
- ;;^UTILITY(U,$J,358.4,288,0)
- ;;=SUSPECTED COND R/O AFTER OBS^25^32
- ;;^UTILITY(U,$J,358.4,289,0)
- ;;=NEW PATIENT^2^33
- ;;^UTILITY(U,$J,358.4,290,0)
- ;;=ESTABLISHED PATIENT^1^33
- ;;^UTILITY(U,$J,358.4,291,0)
- ;;=CONSULTATIONS^3^33
- ;;^UTILITY(U,$J,358.4,292,0)
- ;;=ENDOCRINE DX^1^34
- ;;^UTILITY(U,$J,358.4,293,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^3^34
- ;;^UTILITY(U,$J,358.4,294,0)
- ;;=SOCIAL DETERMINANTS OF HEALTH^2^34
- ;;^UTILITY(U,$J,358.4,295,0)
- ;;=BIOPSIES^1^35
- ;;^UTILITY(U,$J,358.4,296,0)
- ;;=INJECTIONS & INFUSIONS^2^35
- ;;^UTILITY(U,$J,358.4,297,0)
- ;;=OTHER^4^35
- ;;^UTILITY(U,$J,358.4,298,0)
- ;;=PROLONGED CLINICAL STAFF SERVICES^5^35
- ;;^UTILITY(U,$J,358.4,299,0)
- ;;=LAB TESTS^3^35
- ;;^UTILITY(U,$J,358.4,300,0)
- ;;=TEST - CATARACT / COLOR^4^36
- ;;^UTILITY(U,$J,358.4,301,0)
- ;;=IMAGING / PHOTOS^2^36
- ;;^UTILITY(U,$J,358.4,302,0)
- ;;=TEST - GLAUCOMA^3^36
- ;;^UTILITY(U,$J,358.4,303,0)
- ;;=TEST - OTHER^5^36
- ;;^UTILITY(U,$J,358.4,304,0)
- ;;=REFRACT / GLASSES / CL^1^36
- ;;^UTILITY(U,$J,358.4,305,0)
- ;;=EEF Version 2022 July^6^36
- ;;^UTILITY(U,$J,358.4,306,0)
- ;;=LOW VISION / BLINDNESS^21^37
- ;;^UTILITY(U,$J,358.4,307,0)
- ;;=RETINA - VASCULAR^12^37
- ;;^UTILITY(U,$J,358.4,308,0)
- ;;=EYELIDS / LASHES^2^37
- ;;^UTILITY(U,$J,358.4,309,0)
- ;;=NEURO / STRABISMUS^18^37
- ;;^UTILITY(U,$J,358.4,310,0)
- ;;=ORBIT - PLASTICS^20^37
- ;;^UTILITY(U,$J,358.4,311,0)
- ;;=VITREOUS^17^37
- ;;^UTILITY(U,$J,358.4,312,0)
- ;;=ORBIT - TRAUMA^19^37
- ;;^UTILITY(U,$J,358.4,313,0)
- ;;=LACRIMAL / NLD / NEOPLASMS^3^37
- ;;^UTILITY(U,$J,358.4,314,0)
- ;;=MOST FREQUENT^1^37
- ;;^UTILITY(U,$J,358.4,315,0)
- ;;=CONJUNCTIVA / SCLERA^4^37
- ;;^UTILITY(U,$J,358.4,316,0)
- ;;=CORNEA / ULCER^5^37
- ;;^UTILITY(U,$J,358.4,317,0)
- ;;=LENS / CATARACT / POSTOP^6^37
- ;;^UTILITY(U,$J,358.4,318,0)
- ;;=IRIS / UVEITIS^7^37
- ;;^UTILITY(U,$J,358.4,319,0)
- ;;=GLAUCOMA - OPEN ANGLE^8^37
- ;;^UTILITY(U,$J,358.4,320,0)
- ;;=GLAUCOMA - CLOSED ANGLE^9^37
- ;;^UTILITY(U,$J,358.4,321,0)
- ;;=GLAUCOMA - SECONDARY^10^37
- ;;^UTILITY(U,$J,358.4,322,0)
- ;;=RETINA - CHOROID / TUMORS / INFLAM^14^37
- ;;^UTILITY(U,$J,358.4,323,0)
- ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^37
- ;;^UTILITY(U,$J,358.4,324,0)
- ;;=RETINA - MACULA^11^37
- ;;^UTILITY(U,$J,358.4,325,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^23^37
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0BE 19790 printed Mar 13, 2025@20:50:01 Page 2
- IBDEI0BE ; ; 01-AUG-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4)
- +2 ;;=^IBE(358.4,
- +3 ;;^UTILITY(U,$J,358.4,0)
- +4 ;;=IMP/EXP SELECTION GROUP^358.4I^1182^1174
- +5 ;;^UTILITY(U,$J,358.4,1,0)
- +6 ;;=PHYSICIAN TELEPHONE CODES^1^1
- +7 ;;^UTILITY(U,$J,358.4,2,0)
- +8 ;;=NON-PHYSICIAN TELEPHONE CALLS^2^1
- +9 ;;^UTILITY(U,$J,358.4,3,0)
- +10 ;;=SEIZURES/EPILEPSY/SPELLS^1^2
- +11 ;;^UTILITY(U,$J,358.4,4,0)
- +12 ;;=CEREBROVASCULAR DISEASE^2^2
- +13 ;;^UTILITY(U,$J,358.4,5,0)
- +14 ;;=DIZZINESS^3^2
- +15 ;;^UTILITY(U,$J,358.4,6,0)
- +16 ;;=ENCEPHALOPATHY^4^2
- +17 ;;^UTILITY(U,$J,358.4,7,0)
- +18 ;;=HEADACHE^5^2
- +19 ;;^UTILITY(U,$J,358.4,8,0)
- +20 ;;=MOVEMENT DISORDERS^6^2
- +21 ;;^UTILITY(U,$J,358.4,9,0)
- +22 ;;=NEOPLASMS^7^2
- +23 ;;^UTILITY(U,$J,358.4,10,0)
- +24 ;;=NEURODEGENERATIVE DISEASE^8^2
- +25 ;;^UTILITY(U,$J,358.4,11,0)
- +26 ;;=SLEEP DISORDERS^9^2
- +27 ;;^UTILITY(U,$J,358.4,12,0)
- +28 ;;=SPECIAL SCREENING^10^2
- +29 ;;^UTILITY(U,$J,358.4,13,0)
- +30 ;;=OTHER^11^2
- +31 ;;^UTILITY(U,$J,358.4,14,0)
- +32 ;;=BODY MASS INDEX (BMI)^2^3
- +33 ;;^UTILITY(U,$J,358.4,15,0)
- +34 ;;=COUNSELING^3^3
- +35 ;;^UTILITY(U,$J,358.4,16,0)
- +36 ;;=PREVENTIVE HEALTH ENCOUNTER^1^3
- +37 ;;^UTILITY(U,$J,358.4,17,0)
- +38 ;;=HISTORY OF ILLNESS^4^3
- +39 ;;^UTILITY(U,$J,358.4,18,0)
- +40 ;;=LONG TERM DRUG USE^5^3
- +41 ;;^UTILITY(U,$J,358.4,19,0)
- +42 ;;=OTHER^11^3
- +43 ;;^UTILITY(U,$J,358.4,20,0)
- +44 ;;=SCREENING^6^3
- +45 ;;^UTILITY(U,$J,358.4,21,0)
- +46 ;;=TRANSPLANT^8^3
- +47 ;;^UTILITY(U,$J,358.4,22,0)
- +48 ;;=VACCINATIONS^9^3
- +49 ;;^UTILITY(U,$J,358.4,23,0)
- +50 ;;=WOMEN'S HEALTH^10^3
- +51 ;;^UTILITY(U,$J,358.4,24,0)
- +52 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^3
- +53 ;;^UTILITY(U,$J,358.4,25,0)
- +54 ;;=IMMUNIZATIONS^4^4
- +55 ;;^UTILITY(U,$J,358.4,26,0)
- +56 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^4
- +57 ;;^UTILITY(U,$J,358.4,27,0)
- +58 ;;=COUNSELING RISK FACTOR REDUCTION^2^4
- +59 ;;^UTILITY(U,$J,358.4,28,0)
- +60 ;;=OTH PREVENTIVE MEDICINE SERVICES^5^4
- +61 ;;^UTILITY(U,$J,358.4,29,0)
- +62 ;;=PREVENTIVE MEDICINE,GROUP^8^4
- +63 ;;^UTILITY(U,$J,358.4,30,0)
- +64 ;;=PREVENTIVE HEALTH VISIT-EST PT^6^4
- +65 ;;^UTILITY(U,$J,358.4,31,0)
- +66 ;;=PREVENTIVE HEALTH VISIT-NEW PT^7^4
- +67 ;;^UTILITY(U,$J,358.4,32,0)
- +68 ;;=IMMUNIZATION ADMINISTRATION^3^4
- +69 ;;^UTILITY(U,$J,358.4,33,0)
- +70 ;;=RESPIRATORY^6^5
- +71 ;;^UTILITY(U,$J,358.4,34,0)
- +72 ;;=SLEEP TESTING AND EVAL^7^5
- +73 ;;^UTILITY(U,$J,358.4,35,0)
- +74 ;;=OXIMETRY^4^5
- +75 ;;^UTILITY(U,$J,358.4,36,0)
- +76 ;;=CPAP^1^5
- +77 ;;^UTILITY(U,$J,358.4,37,0)
- +78 ;;=EDUCATION/TRAINING^2^5
- +79 ;;^UTILITY(U,$J,358.4,38,0)
- +80 ;;=PROLONGED CLINICAL STAFF SERVICES^5^5
- +81 ;;^UTILITY(U,$J,358.4,39,0)
- +82 ;;=HOME SLEEP STUDIES^3^5
- +83 ;;^UTILITY(U,$J,358.4,40,0)
- +84 ;;=TELEHEALTH PATIENT SITE^8^5
- +85 ;;^UTILITY(U,$J,358.4,41,0)
- +86 ;;=WIRELESS MONITOR OF PAP DEVICES^9^5
- +87 ;;^UTILITY(U,$J,358.4,42,0)
- +88 ;;=NEW PATIENT^2^6
- +89 ;;^UTILITY(U,$J,358.4,43,0)
- +90 ;;=ESTABLISHED PATIENT^1^6
- +91 ;;^UTILITY(U,$J,358.4,44,0)
- +92 ;;=CONSULTATIONS^3^6
- +93 ;;^UTILITY(U,$J,358.4,45,0)
- +94 ;;=PULMONARY DIAGNOSES^2^7
- +95 ;;^UTILITY(U,$J,358.4,46,0)
- +96 ;;=SLEEP DX PRELIMINARY^3^7
- +97 ;;^UTILITY(U,$J,358.4,47,0)
- +98 ;;=SLEEP DX CONFIRMED^4^7
- +99 ;;^UTILITY(U,$J,358.4,48,0)
- +100 ;;=OTHER SLEEP RELATED DX^6^7
- +101 ;;^UTILITY(U,$J,358.4,49,0)
- +102 ;;=SUICIDE IDEATIONS/ATTEMPTS^5^7
- +103 ;;^UTILITY(U,$J,358.4,50,0)
- +104 ;;=OBESITY & BMI DX^1^7
- +105 ;;^UTILITY(U,$J,358.4,51,0)
- +106 ;;=SPECIAL SERVICES^10^8
- +107 ;;^UTILITY(U,$J,358.4,52,0)
- +108 ;;=CHEMO NURSE PROCEDURES^2^8
- +109 ;;^UTILITY(U,$J,358.4,53,0)
- +110 ;;=INFUSION DRUGS^7^8
- +111 ;;^UTILITY(U,$J,358.4,54,0)
- +112 ;;=BLOOD PRODUCTS^1^8
- +113 ;;^UTILITY(U,$J,358.4,55,0)
- +114 ;;=DIAGNOSTIC PROCEDURES^3^8
- +115 ;;^UTILITY(U,$J,358.4,56,0)
- +116 ;;=OTHER DRUGS^8^8
- +117 ;;^UTILITY(U,$J,358.4,57,0)
- +118 ;;=IMMUNIZATION ADMINISTRATION^5^8
- +119 ;;^UTILITY(U,$J,358.4,58,0)
- +120 ;;=IMMUNIZATIONS^6^8
- +121 ;;^UTILITY(U,$J,358.4,59,0)
- +122 ;;=PROLONGED SVC-MD/NP/PA^9^8
- +123 ;;^UTILITY(U,$J,358.4,60,0)
- +124 ;;=EDUCATION/TRAINING^4^8
- +125 ;;^UTILITY(U,$J,358.4,61,0)
- +126 ;;=NEW PATIENT^2^9
- +127 ;;^UTILITY(U,$J,358.4,62,0)
- +128 ;;=ESTABLISHED PATIENT^1^9
- +129 ;;^UTILITY(U,$J,358.4,63,0)
- +130 ;;=CONSULTATIONS^3^9
- +131 ;;^UTILITY(U,$J,358.4,64,0)
- +132 ;;=COMPLEX CHRONIC CARE^4^9
- +133 ;;^UTILITY(U,$J,358.4,65,0)
- +134 ;;=ANEMIA^1^10
- +135 ;;^UTILITY(U,$J,358.4,66,0)
- +136 ;;=ARTIFICIAL OPENING STATUS^2^10
- +137 ;;^UTILITY(U,$J,358.4,67,0)
- +138 ;;=BREASTS and GYN NEOPLASMS^3^10
- +139 ;;^UTILITY(U,$J,358.4,68,0)
- +140 ;;=COAGULATION DISORDERS^4^10
- +141 ;;^UTILITY(U,$J,358.4,69,0)
- +142 ;;=COUNSELING AND SCREENING^5^10
- +143 ;;^UTILITY(U,$J,358.4,70,0)
- +144 ;;=GENITOURINARY NEOPLASMS^6^10
- +145 ;;^UTILITY(U,$J,358.4,71,0)
- +146 ;;=GI CANCER^7^10
- +147 ;;^UTILITY(U,$J,358.4,72,0)
- +148 ;;=HEAD NECK AND LUNGS NEOPLASMS^8^10
- +149 ;;^UTILITY(U,$J,358.4,73,0)
- +150 ;;=HEMOGLOBINOPATHIES^9^10
- +151 ;;^UTILITY(U,$J,358.4,74,0)
- +152 ;;=LYMPHOID NEOPLASMS^10^10
- +153 ;;^UTILITY(U,$J,358.4,75,0)
- +154 ;;=METASTATIC SITES^13^10
- +155 ;;^UTILITY(U,$J,358.4,76,0)
- +156 ;;=MALIGNANT NEOPLASMS OF OTHER SITES^11^10
- +157 ;;^UTILITY(U,$J,358.4,77,0)
- +158 ;;=MYELOID NEOPLASMS AND DISORDERS^14^10
- +159 ;;^UTILITY(U,$J,358.4,78,0)
- +160 ;;=NEOPLASM OF UNCERTAIN BEHAVIOR^15^10
- +161 ;;^UTILITY(U,$J,358.4,79,0)
- +162 ;;=NEOPLASM OF UNSPECIFIED NATURE^16^10
- +163 ;;^UTILITY(U,$J,358.4,80,0)
- +164 ;;=PERSONAL HISTORY^19^10
- +165 ;;^UTILITY(U,$J,358.4,81,0)
- +166 ;;=MALNUTRITION^12^10
- +167 ;;^UTILITY(U,$J,358.4,82,0)
- +168 ;;=OTHER^18^10
- +169 ;;^UTILITY(U,$J,358.4,83,0)
- +170 ;;=SUICIDE IDEATIONS/ATTEMPTS^20^10
- +171 ;;^UTILITY(U,$J,358.4,84,0)
- +172 ;;=ESTABLISHED PATIENT^1^11
- +173 ;;^UTILITY(U,$J,358.4,85,0)
- +174 ;;=CONSULTATIONS/OPINIONS^2^11
- +175 ;;^UTILITY(U,$J,358.4,86,0)
- +176 ;;=NEW PATIENTS^3^11
- +177 ;;^UTILITY(U,$J,358.4,87,0)
- +178 ;;=NEUROLOGY/SEIZURE^7^12
- +179 ;;^UTILITY(U,$J,358.4,88,0)
- +180 ;;=EEG^4^12
- +181 ;;^UTILITY(U,$J,358.4,89,0)
- +182 ;;=SLEEP TESTING^10^12
- +183 ;;^UTILITY(U,$J,358.4,90,0)
- +184 ;;=MUSCLE TESTING/EMG^6^12
- +185 ;;^UTILITY(U,$J,358.4,91,0)
- +186 ;;=EVOKED POTENTIAL^5^12
- +187 ;;^UTILITY(U,$J,358.4,92,0)
- +188 ;;=BIOPSY^2^12
- +189 ;;^UTILITY(U,$J,358.4,93,0)
- +190 ;;=AUTONOMIC FUNCTION TESTS^1^12
- +191 ;;^UTILITY(U,$J,358.4,94,0)
- +192 ;;=STEREOTACTIC^11^12
- +193 ;;^UTILITY(U,$J,358.4,95,0)
- +194 ;;=EDUCATION^3^12
- +195 ;;^UTILITY(U,$J,358.4,96,0)
- +196 ;;=NEUROSTIMULATORS^8^12
- +197 ;;^UTILITY(U,$J,358.4,97,0)
- +198 ;;=PROLONGED SERVICES^9^12
- +199 ;;^UTILITY(U,$J,358.4,98,0)
- +200 ;;=SEIZURES/EPILEPSY/SPELLS^16^13
- +201 ;;^UTILITY(U,$J,358.4,99,0)
- +202 ;;=CEREBROVASCULAR DISEASE^3^13
- +203 ;;^UTILITY(U,$J,358.4,100,0)
- +204 ;;=DIZZINESS^4^13
- +205 ;;^UTILITY(U,$J,358.4,101,0)
- +206 ;;=ENCEPHALOPATHY^6^13
- +207 ;;^UTILITY(U,$J,358.4,102,0)
- +208 ;;=HEADACHE^7^13
- +209 ;;^UTILITY(U,$J,358.4,103,0)
- +210 ;;=MOVEMENT DISORDERS^9^13
- +211 ;;^UTILITY(U,$J,358.4,104,0)
- +212 ;;=NEOPLASMS^11^13
- +213 ;;^UTILITY(U,$J,358.4,105,0)
- +214 ;;=NEURODEGENERATIVE DISEASE^12^13
- +215 ;;^UTILITY(U,$J,358.4,106,0)
- +216 ;;=OTHER^14^13
- +217 ;;^UTILITY(U,$J,358.4,107,0)
- +218 ;;=CARDIAC DISORDERS^2^13
- +219 ;;^UTILITY(U,$J,358.4,108,0)
- +220 ;;=INFLAMMATORY & DEMYELINATING DISEASES^8^13
- +221 ;;^UTILITY(U,$J,358.4,109,0)
- +222 ;;=NEUROMUSCULAR DISORDERS^13^13
- +223 ;;^UTILITY(U,$J,358.4,110,0)
- +224 ;;=PAIN^15^13
- +225 ;;^UTILITY(U,$J,358.4,111,0)
- +226 ;;=SPINAL CONDITIONS^18^13
- +227 ;;^UTILITY(U,$J,358.4,112,0)
- +228 ;;=SYMPTOMS^20^13
- +229 ;;^UTILITY(U,$J,358.4,113,0)
- +230 ;;=VISION DISTURBANCES^21^13
- +231 ;;^UTILITY(U,$J,358.4,114,0)
- +232 ;;=EMG DX^5^13
- +233 ;;^UTILITY(U,$J,358.4,115,0)
- +234 ;;=SUICIDE IDEATIONS/ATTEMPTS^19^13
- +235 ;;^UTILITY(U,$J,358.4,116,0)
- +236 ;;=MUSCLE ATROPHY^10^13
- +237 ;;^UTILITY(U,$J,358.4,117,0)
- +238 ;;=BOTOX^1^13
- +239 ;;^UTILITY(U,$J,358.4,118,0)
- +240 ;;=SEQUELAE OF CEREBROVASCULAR DISEASE^17^13
- +241 ;;^UTILITY(U,$J,358.4,119,0)
- +242 ;;=ESTABLISHED PATIENT^1^14
- +243 ;;^UTILITY(U,$J,358.4,120,0)
- +244 ;;=CARE PLAN OVERSIGHT^1^15
- +245 ;;^UTILITY(U,$J,358.4,121,0)
- +246 ;;=OTHER SERVICES^4^15
- +247 ;;^UTILITY(U,$J,358.4,122,0)
- +248 ;;=CASE MANAGEMENT^2^15
- +249 ;;^UTILITY(U,$J,358.4,123,0)
- +250 ;;=EDUCATION^3^15
- +251 ;;^UTILITY(U,$J,358.4,124,0)
- +252 ;;=CARDIOVASCULAR DISORDERS^1^16
- +253 ;;^UTILITY(U,$J,358.4,125,0)
- +254 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^16
- +255 ;;^UTILITY(U,$J,358.4,126,0)
- +256 ;;=DIABETES^4^16
- +257 ;;^UTILITY(U,$J,358.4,127,0)
- +258 ;;=EYE & EAR DISORDERS^4^16
- +259 ;;^UTILITY(U,$J,358.4,128,0)
- +260 ;;=MENTAL HEALTH^5^16
- +261 ;;^UTILITY(U,$J,358.4,129,0)
- +262 ;;=NEOPLASMS^6^16
- +263 ;;^UTILITY(U,$J,358.4,130,0)
- +264 ;;=NEUROLOGICAL CONDITIONS^7^16
- +265 ;;^UTILITY(U,$J,358.4,131,0)
- +266 ;;=OTHER CONDITIONS^8^16
- +267 ;;^UTILITY(U,$J,358.4,132,0)
- +268 ;;=RESPIRATORY DISORDERS^9^16
- +269 ;;^UTILITY(U,$J,358.4,133,0)
- +270 ;;=DEMENTIA^3^16
- +271 ;;^UTILITY(U,$J,358.4,134,0)
- +272 ;;=SUICIDE IDEATIONS/ATTEMPTS^10^16
- +273 ;;^UTILITY(U,$J,358.4,135,0)
- +274 ;;=ASSESSMENT/COUNSELING^1^17
- +275 ;;^UTILITY(U,$J,358.4,136,0)
- +276 ;;=ONE ON ONE TRAINING^6^17
- +277 ;;^UTILITY(U,$J,358.4,137,0)
- +278 ;;=ED/GRP/FAMILY TRNG FOR SELF MGMT^2^17
- +279 ;;^UTILITY(U,$J,358.4,138,0)
- +280 ;;=TEAM CONFERENCE^8^17
- +281 ;;^UTILITY(U,$J,358.4,139,0)
- +282 ;;=HOME VISIT^5^17
- +283 ;;^UTILITY(U,$J,358.4,140,0)
- +284 ;;=IMPAIRMENT CODES^1^18
- +285 ;;^UTILITY(U,$J,358.4,141,0)
- +286 ;;=CONTRIBUTORY CONDITION^2^18
- +287 ;;^UTILITY(U,$J,358.4,142,0)
- +288 ;;=TBI-RELATED CONTRIB COND^5^18
- +289 ;;^UTILITY(U,$J,358.4,143,0)
- +290 ;;=SUICIDE IDEATIONS/ATTEMPTS^4^18
- +291 ;;^UTILITY(U,$J,358.4,144,0)
- +292 ;;=FAMILY HX EYE CONDITIONS^3^18
- +293 ;;^UTILITY(U,$J,358.4,145,0)
- +294 ;;=NEW PATIENT^2^19
- +295 ;;^UTILITY(U,$J,358.4,146,0)
- +296 ;;=ESTABLISHED PATIENT^1^19
- +297 ;;^UTILITY(U,$J,358.4,147,0)
- +298 ;;=CONSULTATIONS^3^19
- +299 ;;^UTILITY(U,$J,358.4,148,0)
- +300 ;;=ARRHYTHMIA^3^20
- +301 ;;^UTILITY(U,$J,358.4,149,0)
- +302 ;;=CHEST PAIN^4^20
- +303 ;;^UTILITY(U,$J,358.4,150,0)
- +304 ;;=CHF/MYOPATHY/TRANSPLANT^5^20
- +305 ;;^UTILITY(U,$J,358.4,151,0)
- +306 ;;=CORONARY ATHEROSCLEROSIS^6^20
- +307 ;;^UTILITY(U,$J,358.4,152,0)
- +308 ;;=GENERAL SYMPTOMS^9^20
- +309 ;;^UTILITY(U,$J,358.4,153,0)
- +310 ;;=HISTORY^12^20
- +311 ;;^UTILITY(U,$J,358.4,154,0)
- +312 ;;=HYPERTENSION/HYPOTENSION^13^20
- +313 ;;^UTILITY(U,$J,358.4,155,0)
- +314 ;;=INFECTION/INFLM DISEASE^14^20
- +315 ;;^UTILITY(U,$J,358.4,156,0)
- +316 ;;=LIPID DISORDER^15^20
- +317 ;;^UTILITY(U,$J,358.4,157,0)
- +318 ;;=MYOCARDIAL INFARCTION^17^20
- +319 ;;^UTILITY(U,$J,358.4,158,0)
- +320 ;;=NONRHEUMATIC HEART VALVE DISORDERS^18^20
- +321 ;;^UTILITY(U,$J,358.4,159,0)
- +322 ;;=HEART DISEASE^10^20
- +323 ;;^UTILITY(U,$J,358.4,160,0)
- +324 ;;=HEART VALVE DISEASE^11^20
- +325 ;;^UTILITY(U,$J,358.4,161,0)
- +326 ;;=PERIPHERAL VASC DISEASE^20^20
- +327 ;;^UTILITY(U,$J,358.4,162,0)
- +328 ;;=RHEUMATIC HEART DISEASE^23^20
- +329 ;;^UTILITY(U,$J,358.4,163,0)
- +330 ;;=DEVICE/IMPLANT/GRAFT^7^20
- +331 ;;^UTILITY(U,$J,358.4,164,0)
- +332 ;;=SYNCOPE^26^20
- +333 ;;^UTILITY(U,$J,358.4,165,0)
- +334 ;;=SUICIDE IDEATIONS/ATTEMPTS^24^20
- +335 ;;^UTILITY(U,$J,358.4,166,0)
- +336 ;;=ECTOPY^8^20
- +337 ;;^UTILITY(U,$J,358.4,167,0)
- +338 ;;=MISCELLANEOUS^16^20
- +339 ;;^UTILITY(U,$J,358.4,168,0)
- +340 ;;=VENTRICULAR ARRHYTHMIAS^27^20
- +341 ;;^UTILITY(U,$J,358.4,169,0)
- +342 ;;=SUPRAVENTRICULAR ARRHYTHMIAS^25^20
- +343 ;;^UTILITY(U,$J,358.4,170,0)
- +344 ;;=OTHER CARDIAC CONDITIONS^22^20
- +345 ;;^UTILITY(U,$J,358.4,171,0)
- +346 ;;=PULMONARY DISEASE^21^20
- +347 ;;^UTILITY(U,$J,358.4,172,0)
- +348 ;;=PACEMAKER/AIC/DEFIBRILLATOR^19^20
- +349 ;;^UTILITY(U,$J,358.4,173,0)
- +350 ;;=ACSC CHF^1^20
- +351 ;;^UTILITY(U,$J,358.4,174,0)
- +352 ;;=ACSC HYPERTENSION^2^20
- +353 ;;^UTILITY(U,$J,358.4,175,0)
- +354 ;;=PACEMAKER^15^21
- +355 ;;^UTILITY(U,$J,358.4,176,0)
- +356 ;;=CORONARY ANGIOPLASTY & STENTS^3^21
- +357 ;;^UTILITY(U,$J,358.4,177,0)
- +358 ;;=ELECTROPHYSIOLOGICAL PROCs^7^21
- +359 ;;^UTILITY(U,$J,358.4,178,0)
- +360 ;;=PERIPHERAL ANGIOPLASTIES & STENTS^16^21
- +361 ;;^UTILITY(U,$J,358.4,179,0)
- +362 ;;=VASCULAR INJECTION PROCs^21^21
- +363 ;;^UTILITY(U,$J,358.4,180,0)
- +364 ;;=OTHER PROCEDURES^14^21
- +365 ;;^UTILITY(U,$J,358.4,181,0)
- +366 ;;=HEART CATHETERIZATIONS^8^21
- +367 ;;^UTILITY(U,$J,358.4,182,0)
- +368 ;;=CATHETERIZATIONS FOR INT RADIOLOGY^2^21
- +369 ;;^UTILITY(U,$J,358.4,183,0)
- +370 ;;=OTHER HEART CODES^13^21
- +371 ;;^UTILITY(U,$J,358.4,184,0)
- +372 ;;=PROSTHETIC ANEURYSM REPAIR^19^21
- +373 ;;^UTILITY(U,$J,358.4,185,0)
- +374 ;;=DEVICE PROGRAMMING^4^21
- +375 ;;^UTILITY(U,$J,358.4,186,0)
- +376 ;;=ECHO^5^21
- +377 ;;^UTILITY(U,$J,358.4,187,0)
- +378 ;;=EKG^6^21
- +379 ;;^UTILITY(U,$J,358.4,188,0)
- +380 ;;=MEDICATION ADMINISTRATION^9^21
- +381 ;;^UTILITY(U,$J,358.4,189,0)
- +382 ;;=MEDICATIONS^10^21
- +383 ;;^UTILITY(U,$J,358.4,190,0)
- +384 ;;=OTHER CARDIAC^12^21
- +385 ;;^UTILITY(U,$J,358.4,191,0)
- +386 ;;=STRESS TESTS^20^21
- +387 ;;^UTILITY(U,$J,358.4,192,0)
- +388 ;;=PREVENTIVE COUNSELING^17^21
- +389 ;;^UTILITY(U,$J,358.4,193,0)
- +390 ;;=MODERATE SEDATION (MS)^11^21
- +391 ;;^UTILITY(U,$J,358.4,194,0)
- +392 ;;=VENTRICULAR ASSIST DEVICE INSERTION^22^21
- +393 ;;^UTILITY(U,$J,358.4,195,0)
- +394 ;;=CARDIOVERSION^1^21
- +395 ;;^UTILITY(U,$J,358.4,196,0)
- +396 ;;=PROLONGED SERVICES^18^21
- +397 ;;^UTILITY(U,$J,358.4,197,0)
- +398 ;;=NEW PATIENT^2^22
- +399 ;;^UTILITY(U,$J,358.4,198,0)
- +400 ;;=ESTABLISHED PATIENT^1^22
- +401 ;;^UTILITY(U,$J,358.4,199,0)
- +402 ;;=CONSULTATIONS^3^22
- +403 ;;^UTILITY(U,$J,358.4,200,0)
- +404 ;;=MISCELLANEOUS TREATMENT^4^23
- +405 ;;^UTILITY(U,$J,358.4,201,0)
- +406 ;;=CHIROPRACTIC MANIPULATIVE SERVICES^2^23
- +407 ;;^UTILITY(U,$J,358.4,202,0)
- +408 ;;=OSTEOPATHIC MANIPULATIVE TREATMENT^5^23
- +409 ;;^UTILITY(U,$J,358.4,203,0)
- +410 ;;=ACUPUNCTURE^1^23
- +411 ;;^UTILITY(U,$J,358.4,204,0)
- +412 ;;=EDUCATION FOR SELF MGT^3^23
- +413 ;;^UTILITY(U,$J,358.4,205,0)
- +414 ;;=EXTREMITIES/JOINTS/MUSCLES^6^24
- +415 ;;^UTILITY(U,$J,358.4,206,0)
- +416 ;;=HEAD AREA/NERVES^1^24
- +417 ;;^UTILITY(U,$J,358.4,207,0)
- +418 ;;=CERVICAL^2^24
- +419 ;;^UTILITY(U,$J,358.4,208,0)
- +420 ;;=THORACIC^3^24
- +421 ;;^UTILITY(U,$J,358.4,209,0)
- +422 ;;=LUMBAR^4^24
- +423 ;;^UTILITY(U,$J,358.4,210,0)
- +424 ;;=SACRUM^5^24
- +425 ;;^UTILITY(U,$J,358.4,211,0)
- +426 ;;=UNSPECIFIED^8^24
- +427 ;;^UTILITY(U,$J,358.4,212,0)
- +428 ;;=SUICIDE IDEATIONS/ATTEMPTS^7^24
- +429 ;;^UTILITY(U,$J,358.4,213,0)
- +430 ;;=NEW PATIENT^1^25
- +431 ;;^UTILITY(U,$J,358.4,214,0)
- +432 ;;=ESTABLISHED PATIENT^2^25
- +433 ;;^UTILITY(U,$J,358.4,215,0)
- +434 ;;=EDUCATION & TRAINING FOR SELF MGMT^4^25
- +435 ;;^UTILITY(U,$J,358.4,216,0)
- +436 ;;=MEDICATION ADMIN^7^25
- +437 ;;^UTILITY(U,$J,358.4,217,0)
- +438 ;;=IMMUNIZATION ADMINISTRATION^5^25
- +439 ;;^UTILITY(U,$J,358.4,218,0)
- +440 ;;=IMMUNIZATIONS^6^25
- +441 ;;^UTILITY(U,$J,358.4,219,0)
- +442 ;;=CONTINUOUS GLUCOSE MONITORING^3^25
- +443 ;;^UTILITY(U,$J,358.4,220,0)
- +444 ;;=ANTICOAGULATION^2^26
- +445 ;;^UTILITY(U,$J,358.4,221,0)
- +446 ;;=PAIN^6^26
- +447 ;;^UTILITY(U,$J,358.4,222,0)
- +448 ;;=MENTAL HEALTH^5^26
- +449 ;;^UTILITY(U,$J,358.4,223,0)
- +450 ;;=ENDOCRINE^4^26
- +451 ;;^UTILITY(U,$J,358.4,224,0)
- +452 ;;=CARDIOVASCULAR^3^26
- +453 ;;^UTILITY(U,$J,358.4,225,0)
- +454 ;;=RESPIRATORY^7^26
- +455 ;;^UTILITY(U,$J,358.4,226,0)
- +456 ;;=OTHER^8^26
- +457 ;;^UTILITY(U,$J,358.4,227,0)
- +458 ;;=COMMON DIAGNOSIS^1^26
- +459 ;;^UTILITY(U,$J,358.4,228,0)
- +460 ;;=NEW PATIENT^3^27
- +461 ;;^UTILITY(U,$J,358.4,229,0)
- +462 ;;=ESTABLISHED PATIENT^1^27
- +463 ;;^UTILITY(U,$J,358.4,230,0)
- +464 ;;=CONSULTATIONS^2^27
- +465 ;;^UTILITY(U,$J,358.4,231,0)
- +466 ;;=PREVENTIVE MEDICINE-EST PT^4^27
- +467 ;;^UTILITY(U,$J,358.4,232,0)
- +468 ;;=PREVENTIVE MEDICINE-NEW PT^5^27
- +469 ;;^UTILITY(U,$J,358.4,233,0)
- +470 ;;=RISK FACTOR REDUCTION-GRP^6^27
- +471 ;;^UTILITY(U,$J,358.4,234,0)
- +472 ;;=RISK FACTOR REDUCTION-IND^7^27
- +473 ;;^UTILITY(U,$J,358.4,235,0)
- +474 ;;=OTHER^3^28
- +475 ;;^UTILITY(U,$J,358.4,236,0)
- +476 ;;=EDUCATION/TRAINING^1^28
- +477 ;;^UTILITY(U,$J,358.4,237,0)
- +478 ;;=MEDICAL NUTRITION THERAPY^2^28
- +479 ;;^UTILITY(U,$J,358.4,238,0)
- +480 ;;=WOUND TREATMENT^5^28
- +481 ;;^UTILITY(U,$J,358.4,239,0)
- +482 ;;=PROLONGED SERVICES^4^28
- +483 ;;^UTILITY(U,$J,358.4,240,0)
- +484 ;;=DIABETES^1^29
- +485 ;;^UTILITY(U,$J,358.4,241,0)
- +486 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^29
- +487 ;;^UTILITY(U,$J,358.4,242,0)
- +488 ;;=SOCIAL DETERMINANTS OF HEALTH^2^29
- +489 ;;^UTILITY(U,$J,358.4,243,0)
- +490 ;;=IMMUNIZATION^10^30
- +491 ;;^UTILITY(U,$J,358.4,244,0)
- +492 ;;=MEDICATION^13^30
- +493 ;;^UTILITY(U,$J,358.4,245,0)
- +494 ;;=ORTHO/JOINTS^6^30
- +495 ;;^UTILITY(U,$J,358.4,246,0)
- +496 ;;=RESPIRATORY SYSTEM^14^30
- +497 ;;^UTILITY(U,$J,358.4,247,0)
- +498 ;;=CRITICAL CARE/PULM/SEDATION^3^30
- +499 ;;^UTILITY(U,$J,358.4,248,0)
- +500 ;;=GI/GYN^7^30
- +501 ;;^UTILITY(U,$J,358.4,249,0)
- +502 ;;=NEURO/EYE/ENT^8^30
- +503 ;;^UTILITY(U,$J,358.4,250,0)
- +504 ;;=LACERATIONS^5^30
- +505 ;;^UTILITY(U,$J,358.4,251,0)
- +506 ;;=SKIN WOUNDS/BURNS^4^30
- +507 ;;^UTILITY(U,$J,358.4,252,0)
- +508 ;;=PSYCHIATRY^9^30
- +509 ;;^UTILITY(U,$J,358.4,253,0)
- +510 ;;=COMMON PROCEDURES^1^30
- +511 ;;^UTILITY(U,$J,358.4,254,0)
- +512 ;;=INFUSION/INJECTION ADMIN^11^30
- +513 ;;^UTILITY(U,$J,358.4,255,0)
- +514 ;;=ADDITIONAL VISIT CODES^2^30
- +515 ;;^UTILITY(U,$J,358.4,256,0)
- +516 ;;=COVID-19 RELATED^12^30
- +517 ;;^UTILITY(U,$J,358.4,257,0)
- +518 ;;=HEDIS CODE/MISC HCPCS^15^30
- +519 ;;^UTILITY(U,$J,358.4,258,0)
- +520 ;;=LABS PERFORMED IN ED^16^30
- +521 ;;^UTILITY(U,$J,358.4,259,0)
- +522 ;;=EMERGENCY DEPT VISIT^1^31
- +523 ;;^UTILITY(U,$J,358.4,260,0)
- +524 ;;=TRIAGE ONLY (NO MD SEEN)^4^31
- +525 ;;^UTILITY(U,$J,358.4,261,0)
- +526 ;;=ED OBS 1ST DAY-INIT^3^31
- +527 ;;^UTILITY(U,$J,358.4,262,0)
- +528 ;;=ED OBS (ADMIT&D/C SAME DAY)^2^31
- +529 ;;^UTILITY(U,$J,358.4,263,0)
- +530 ;;=ED COMMON DIAGNOSES^1^32
- +531 ;;^UTILITY(U,$J,358.4,264,0)
- +532 ;;=ADMINISTRATIVE TOPICS^2^32
- +533 ;;^UTILITY(U,$J,358.4,265,0)
- +534 ;;=CARDIOVASCULAR^3^32
- +535 ;;^UTILITY(U,$J,358.4,266,0)
- +536 ;;=EAR/NOSE/THROAT^6^32
- +537 ;;^UTILITY(U,$J,358.4,267,0)
- +538 ;;=ENDO/RENAL/ELECTROLYTES^5^32
- +539 ;;^UTILITY(U,$J,358.4,268,0)
- +540 ;;=EYE^7^32
- +541 ;;^UTILITY(U,$J,358.4,269,0)
- +542 ;;=GI/ABDOMEN^8^32
- +543 ;;^UTILITY(U,$J,358.4,270,0)
- +544 ;;=PSYCHIATRY^17^32
- +545 ;;^UTILITY(U,$J,358.4,271,0)
- +546 ;;=LACERATION(S)^16^32
- +547 ;;^UTILITY(U,$J,358.4,272,0)
- +548 ;;=PULMONARY^18^32
- +549 ;;^UTILITY(U,$J,358.4,273,0)
- +550 ;;=GU/RECTAL^9^32
- +551 ;;^UTILITY(U,$J,358.4,274,0)
- +552 ;;=HEME/ONC/VASCULAR^10^32
- +553 ;;^UTILITY(U,$J,358.4,275,0)
- +554 ;;=INFECTIOUS DISEASE^11^32
- +555 ;;^UTILITY(U,$J,358.4,276,0)
- +556 ;;=MUSCULOSKELETAL/MISC^14^32
- +557 ;;^UTILITY(U,$J,358.4,277,0)
- +558 ;;=NEUROLOGY^15^32
- +559 ;;^UTILITY(U,$J,358.4,278,0)
- +560 ;;=SKIN^19^32
- +561 ;;^UTILITY(U,$J,358.4,279,0)
- +562 ;;=MUSCULOSKELETAL-LE^12^32
- +563 ;;^UTILITY(U,$J,358.4,280,0)
- +564 ;;=MUSCULOSKELETAL-UE^13^32
- +565 ;;^UTILITY(U,$J,358.4,281,0)
- +566 ;;=SUICIDE IDEATIONS/ATTEMPTS^21^32
- +567 ;;^UTILITY(U,$J,358.4,282,0)
- +568 ;;=E-CIG/VAPE LUNG INJURY (EVAL)^4^32
- +569 ;;^UTILITY(U,$J,358.4,283,0)
- +570 ;;=FALLS^22^32
- +571 ;;^UTILITY(U,$J,358.4,284,0)
- +572 ;;=VEHICLE ACCIDENTS^24^32
- +573 ;;^UTILITY(U,$J,358.4,285,0)
- +574 ;;=EXTERNAL CAUSES^26^32
- +575 ;;^UTILITY(U,$J,358.4,286,0)
- +576 ;;=PAIN^20^32
- +577 ;;^UTILITY(U,$J,358.4,287,0)
- +578 ;;=BITES-HUMAN/ANIMAL/INSECT^23^32
- +579 ;;^UTILITY(U,$J,358.4,288,0)
- +580 ;;=SUSPECTED COND R/O AFTER OBS^25^32
- +581 ;;^UTILITY(U,$J,358.4,289,0)
- +582 ;;=NEW PATIENT^2^33
- +583 ;;^UTILITY(U,$J,358.4,290,0)
- +584 ;;=ESTABLISHED PATIENT^1^33
- +585 ;;^UTILITY(U,$J,358.4,291,0)
- +586 ;;=CONSULTATIONS^3^33
- +587 ;;^UTILITY(U,$J,358.4,292,0)
- +588 ;;=ENDOCRINE DX^1^34
- +589 ;;^UTILITY(U,$J,358.4,293,0)
- +590 ;;=SUICIDE IDEATIONS/ATTEMPTS^3^34
- +591 ;;^UTILITY(U,$J,358.4,294,0)
- +592 ;;=SOCIAL DETERMINANTS OF HEALTH^2^34
- +593 ;;^UTILITY(U,$J,358.4,295,0)
- +594 ;;=BIOPSIES^1^35
- +595 ;;^UTILITY(U,$J,358.4,296,0)
- +596 ;;=INJECTIONS & INFUSIONS^2^35
- +597 ;;^UTILITY(U,$J,358.4,297,0)
- +598 ;;=OTHER^4^35
- +599 ;;^UTILITY(U,$J,358.4,298,0)
- +600 ;;=PROLONGED CLINICAL STAFF SERVICES^5^35
- +601 ;;^UTILITY(U,$J,358.4,299,0)
- +602 ;;=LAB TESTS^3^35
- +603 ;;^UTILITY(U,$J,358.4,300,0)
- +604 ;;=TEST - CATARACT / COLOR^4^36
- +605 ;;^UTILITY(U,$J,358.4,301,0)
- +606 ;;=IMAGING / PHOTOS^2^36
- +607 ;;^UTILITY(U,$J,358.4,302,0)
- +608 ;;=TEST - GLAUCOMA^3^36
- +609 ;;^UTILITY(U,$J,358.4,303,0)
- +610 ;;=TEST - OTHER^5^36
- +611 ;;^UTILITY(U,$J,358.4,304,0)
- +612 ;;=REFRACT / GLASSES / CL^1^36
- +613 ;;^UTILITY(U,$J,358.4,305,0)
- +614 ;;=EEF Version 2022 July^6^36
- +615 ;;^UTILITY(U,$J,358.4,306,0)
- +616 ;;=LOW VISION / BLINDNESS^21^37
- +617 ;;^UTILITY(U,$J,358.4,307,0)
- +618 ;;=RETINA - VASCULAR^12^37
- +619 ;;^UTILITY(U,$J,358.4,308,0)
- +620 ;;=EYELIDS / LASHES^2^37
- +621 ;;^UTILITY(U,$J,358.4,309,0)
- +622 ;;=NEURO / STRABISMUS^18^37
- +623 ;;^UTILITY(U,$J,358.4,310,0)
- +624 ;;=ORBIT - PLASTICS^20^37
- +625 ;;^UTILITY(U,$J,358.4,311,0)
- +626 ;;=VITREOUS^17^37
- +627 ;;^UTILITY(U,$J,358.4,312,0)
- +628 ;;=ORBIT - TRAUMA^19^37
- +629 ;;^UTILITY(U,$J,358.4,313,0)
- +630 ;;=LACRIMAL / NLD / NEOPLASMS^3^37
- +631 ;;^UTILITY(U,$J,358.4,314,0)
- +632 ;;=MOST FREQUENT^1^37
- +633 ;;^UTILITY(U,$J,358.4,315,0)
- +634 ;;=CONJUNCTIVA / SCLERA^4^37
- +635 ;;^UTILITY(U,$J,358.4,316,0)
- +636 ;;=CORNEA / ULCER^5^37
- +637 ;;^UTILITY(U,$J,358.4,317,0)
- +638 ;;=LENS / CATARACT / POSTOP^6^37
- +639 ;;^UTILITY(U,$J,358.4,318,0)
- +640 ;;=IRIS / UVEITIS^7^37
- +641 ;;^UTILITY(U,$J,358.4,319,0)
- +642 ;;=GLAUCOMA - OPEN ANGLE^8^37
- +643 ;;^UTILITY(U,$J,358.4,320,0)
- +644 ;;=GLAUCOMA - CLOSED ANGLE^9^37
- +645 ;;^UTILITY(U,$J,358.4,321,0)
- +646 ;;=GLAUCOMA - SECONDARY^10^37
- +647 ;;^UTILITY(U,$J,358.4,322,0)
- +648 ;;=RETINA - CHOROID / TUMORS / INFLAM^14^37
- +649 ;;^UTILITY(U,$J,358.4,323,0)
- +650 ;;=RETINA - TEAR / PERIPH / DEGENERATION^15^37
- +651 ;;^UTILITY(U,$J,358.4,324,0)
- +652 ;;=RETINA - MACULA^11^37
- +653 ;;^UTILITY(U,$J,358.4,325,0)
- +654 ;;=SUICIDE IDEATIONS/ATTEMPTS^23^37